Predictive Oncology Appoints Pamela Bush, Ph.D., MBA, as Chief Business Officer
03 févr. 2023 08h31 HE
|
Predictive Oncology Inc.
EAGAN, Minn., Feb. 03, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) is pleased to announce the appointment of Pamela Bush, Ph.D., MBA, as Chief Business Officer. Dr. Bush will...
Pioneer of Computational Biology Joins the Scientific Advisory Board of Predictive Oncology
12 janv. 2023 08h30 HE
|
Predictive Oncology Inc.
EAGAN, Minn., Jan. 12, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) today announced the appointment of Robert F. Murphy, Ph.D., to the company’s Scientific Advisory Board where...
Distinguished Innovator in Genomics Joins the Scientific Advisory Board of Predictive Oncology
13 déc. 2022 08h30 HE
|
Predictive Oncology Inc.
EAGAN, Minn., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) today announced the appointment of Marc Malandro, Ph.D., to the company’s Scientific Advisory Board where he...
Predictive Oncology Appoints Leading Biopharma Executive Matthew J. Hawryluk Ph.D. to the Board of Directors
05 déc. 2022 08h30 HE
|
Predictive Oncology Inc.
EAGAN, Minn., Dec. 05, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) is pleased to announce the appointment of Matthew J. Hawryluk, Ph.D., (www.predictive-oncology.com) to its...
Predictive Oncology Reports Third Quarter Financial Results
10 nov. 2022 17h15 HE
|
Predictive Oncology Inc.
EAGAN, Minn., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) today announced the financial results for its third quarter ended September 30, 2022, which continue to...
David S. Smith appointed to the Board of Directors of Predictive Oncology
25 oct. 2022 08h30 HE
|
Predictive Oncology Inc.
EAGAN, Minn., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI) is pleased to announce the appointment of David S. Smith, JD, to the company’s Board of Directors. Mr. Smith is a...
Predictive Oncology Announces New Chief Executive Officer Raymond F. Vennare to Lead Company Growth
20 oct. 2022 08h30 HE
|
Predictive Oncology Inc.
EAGAN, Minn., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI) is pleased to announce the appointment of Raymond F. Vennare as Chief Executive Officer and Chairman of the Board,...
Predictive Oncology Strengthens Offerings with GMP Lab and Addition of Leading Expert in Formulation Development
19 sept. 2022 08h30 HE
|
Predictive Oncology Inc.
EAGAN, Minn., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI) today announced several key developments to further strengthen the company’s offerings for pharmaceutical and...
Predictive Oncology Announces CEO Retirement
16 sept. 2022 17h05 HE
|
Predictive Oncology Inc.
EAGAN, Minn., Sept. 16, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI) today announced that J. Melville (“Mel”) Engle will retire as Chief Executive Officer and as Chairman and a member...
Predictive Oncology Reports Second Quarter 2022 Financial Results
11 août 2022 17h15 HE
|
Predictive Oncology Inc.
EAGAN, Minn., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) today announced the financial results for its second quarter ended June 30, 2022, which shows a strong balance...